Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: Provided is an RF switch device and a method of manufacturing the same and, more particularly, to an RF switch device that improves the on-resistance (Ron) of the RF switch by including an integral or integrally formed P diode. The RF switch device includes a first active region on a first substrate as a first base, a second active region on the first substrate spaced apart from the first active region as a second base, and a gate electrode on the first active region and on the second active region.

Abstract: Provided is a method for coating an implant using heat, and more particularly to a method for coating only the surface of an implant with a biocompatible polymer by using heat while maintaining physical characteristics of the implant. The method for coating an implant using heat according to the present invention may effectively introduce a biocompatible polymer onto a three-dimensional material surface and thus may overcome the spatial limitations of light, and enables mass-coating and thus may be effectively used in the manufacture of an implant coated with a biocompatible polymer.

Abstract: An etchant composition and a method of fabricating a semiconductor device, the composition including an inorganic acid; about 0.01 parts by weight to about 0.5 parts by weight of colloidal silica; about 0.01 parts by weight to about 30 parts by weight of an ammonium-based additive; and about 20 parts by weight to about 50 parts by weight of a solvent, all parts by weight being based on 100 parts by weight of the inorganic acid.

Abstract: An etchant composition and a method of fabricating a semiconductor device, the composition including an inorganic acid; about 0.01 parts by weight to about 0.5 parts by weight of colloidal silica; about 0.01 parts by weight to about 30 parts by weight of an ammonium-based additive; and about 20 parts by weight to about 50 parts by weight of a solvent, all parts by weight being based on 100 parts by weight of the inorganic acid.

Abstract: An apparatus for injecting an infusion solution is provided, and the apparatus includes a housing including a receiving part to receive an infusion solution bag in the receiving part and an infusion solution tube connected with the infusion solution bag and withdrawn, and a pressing member received in the receiving part to self-inflate as air is supplied and to press the infusion solution bag.

Abstract: An etchant composition and a method of fabricating a semiconductor device, the composition including an inorganic acid; about 0.01 parts by weight to about 0.5 parts by weight of colloidal silica; about 0.01 parts by weight to about 30 parts by weight of an ammonium-based additive; and about 20 parts by weight to about 50 parts by weight of a solvent, all parts by weight being based on 100 parts by weight of the inorganic acid.

Abstract: An apparatus for separating the main component constituting a raw material from impurities includes: a raw material supply unit for supplying a raw material; a charging unit for charging the raw material supplied from the raw material supply unit; an electrostatic sorting unit for sorting the raw material, which has been charged by the charging unit, according to polarity; and a storage unit for collecting the raw material sorted by and falling from the electrostatic sorting unit, wherein the charging unit includes a charging chamber having a space therein for charging the raw material supplied from the raw material supply unit, and a charging rotor rotatably provided in the charging chamber, for impacting the raw material supplied from the raw material supply unit by the rotating force, thus effectively separating the impurities such as ash and sulfur contained in a raw material, e.g. coal.

Abstract: An apparatus for separating the main component constituting a raw material from impurities includes: a raw material supply unit for supplying a raw material; a charging unit for charging the raw material supplied from the raw material supply unit; an electrostatic sorting unit for sorting the raw material, which has been charged by the charging unit, according to polarity; and a storage unit for collecting the raw material sorted by and falling from the electrostatic sorting unit, wherein the charging unit includes a charging chamber having a space therein for charging the raw material supplied from the raw material supply unit, and a charging rotor rotatably provided in the charging chamber, for impacting the raw material supplied from the raw material supply unit by the rotating force, thus effectively separating the impurities such as ash and sulfur contained in a raw material, e.g. coal.

Abstract: The present invention relates to sesterterpene compounds, to the precursors thereof that are hydrolysable in a living body, or to the pharmaceutically acceptable salts thereof, and also relates to the prevention and treatment efficacy of the sesterterpene compounds with respect to non-insulin dependent diabetes mellitus, diabetic complications (renal failure and foot ulcers caused by diabetes), alcoholic, non-alcoholic, and viral fatty liver diseases, obesity, hyperlipidemia, atherosclerosis, cardiovascular diseases such as atherosclerotic stroke, and cerebropathies (Parkinsonism, schizophrenia and Alzheimer's disease). In addition, the present invention relates to compositions for functional foods, functional beverages, functional cosmetics, and functional feed.

Abstract: A cosmetic composition for preventing and treating acne, contains cryptotanshinone as an effective component. The cosmetic composition containing cryptotanshinone can be safely used without any side effect on skin, and further, can very effectively control the amount of sebum secretion due to inhibition of 5 &agr;-reductase activation, and has superior anti-bacterial and anti-inflammation ability.